MediFind
Condition

Olivopontocerebellar Atrophy

Active Clinical Trials

Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 100
  • Start Date: September 15, 2020
Genetic Mechanism of Conserved Ancestral Haplotype in SCA10
Clinical Trial
Procedure
  • Status: Recruiting
  • Study Type: Procedure
  • Participants: 40
  • Start Date: May 28, 2020
Integrated Functional Evaluation of the Cerebellum
Clinical Trial
Dietary Supplement
  • Status: Recruiting
  • Study Type: Dietary Supplement
  • Participants: 40
  • Start Date: February 24, 2020
A Randomised Controlled Trial on the Clinical Efficacy of Oral Trehalose in Patients With Spinocerebellar Ataxia 3: Clinical & FMRI Correlation
Clinical Trial
Behavioral
  • Status: Recruiting
  • Study Type: Behavioral
  • Participants: 32
  • Start Date: January 13, 2020
Effects of Aerobic Exercise Verse Balance Training on Degenerative Cerebellar Disease Using MRI and Gait Analysis
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 210
  • Start Date: June 27, 2019
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 144
  • Start Date: June 1, 2019
APDM Instrumented Data Exchange for Ataxia (IDEA) Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 210
  • Start Date: March 8, 2019
A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult Subjects With Spinocerebellar Ataxia.
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 200
  • Start Date: February 21, 2019
Identification of Biomarkers in Spinocerebellar Ataxia 3
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 70
  • Start Date: November 19, 2018
Effect of Nilotinib in Cerebellar Ataxia Patients
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 200
  • Start Date: August 16, 2018
Clinical Trial Readiness for SCA1 and SCA3